US20110137571A1 - Meter having multi-level user interface - Google Patents

Meter having multi-level user interface Download PDF

Info

Publication number
US20110137571A1
US20110137571A1 US13/028,308 US201113028308A US2011137571A1 US 20110137571 A1 US20110137571 A1 US 20110137571A1 US 201113028308 A US201113028308 A US 201113028308A US 2011137571 A1 US2011137571 A1 US 2011137571A1
Authority
US
United States
Prior art keywords
user
predefined
level
meter
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/028,308
Inventor
Barry D. Power
Jeffrey A. Culver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BARNES HEALTHCARE LLC
Ascensia Diabetes Care Holdings AG
Original Assignee
Bayer Healthcare LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare LLC filed Critical Bayer Healthcare LLC
Priority to US13/028,308 priority Critical patent/US20110137571A1/en
Assigned to BARNES HEALTHCARE LLC reassignment BARNES HEALTHCARE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CULVER, JEFFREY A., POWER, BARRY D.
Publication of US20110137571A1 publication Critical patent/US20110137571A1/en
Assigned to ASCENSIA DIABETES CARE HOLDINGS AG reassignment ASCENSIA DIABETES CARE HOLDINGS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAYER HEALTHCARE LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/742Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/7435Displaying user selection data, e.g. icons in a graphical user interface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475User input or interface means, e.g. keyboard, pointing device, joystick
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48785Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network

Definitions

  • the present disclosure relates generally to meters and methods of using the same, and more particularly, to a meter having a multi-level user interface that allows a user to select one of a plurality of predefined levels of user features.
  • analytes in body fluids are of great importance in the diagnoses and maintenance of certain physiological abnormalities. For example, lactate, cholesterol, bilirubin and glucose should be monitored in certain individuals. In particular, determining glucose in body fluids is important to diabetic individuals who must frequently check the glucose concentration in their body fluids to regulate the glucose intake in their diets.
  • Some existing glucose meters are adapted to allow users to program certain features of the glucose meter. With these types of glucose meters, the user must have some knowledge of how to program the meter or must be able to read and understand often complex user instructions.
  • some glucose meters are not adapted to receive user input and instead have pre-programmed features that do not allow a user to customize the glucose meter. It would be desirable to allow a user to easily customize the glucose meter.
  • the glucose meter includes a display adapted to display information to a user of the meter and an interface that controls the display for the user.
  • the interface has a plurality of predefined levels of user features that are adapted to be selected by the user.
  • the glucose meter further includes at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
  • a method for using a meter is disclosed according to one embodiment of the present disclosure.
  • the meter is adapted to determine and store an analyte concentration reading.
  • the meter includes a display adapted to display information to a user.
  • the method comprises the steps of displaying information on the display via a user interface having a plurality of predefined levels of user features.
  • the method further comprises selecting one of the plurality of predefined levels and displaying the user features associated with the selected predefined level.
  • a meter adapted to determine and store an analyte concentration reading includes a display adapted to display information to a user of the meter and an interface that controls the display for the user.
  • the interface has at least three predefined levels of user features that are adapted to be selected by the user.
  • the meter further includes at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
  • a method for using a meter adapted to determine and store an analyte concentration reading in which the meter has a display adapted to display information to a user, includes the acts of displaying information on the display via a user interface having at least three predefined levels of user features, selecting one of the at least three predefined levels, and displaying the user features associated with the selected predefined level.
  • FIGS. 1 a and 1 b are front views of a meter having a first predefined level of user features, according to one embodiment of the present disclosure.
  • FIGS. 2 a , 2 b and 2 c are front views of a meter having a second predefined level of user features, according to another embodiment of the present disclosure.
  • FIGS. 3 a , 3 b , 3 c and 3 d are front views of a meter having a third predefined level of user features, according to a further embodiment of the present disclosure.
  • FIG. 4 is a front view of a meter having a computer data interface.
  • the present disclosure is directed to a meter that is adapted to determine and store an analyte concentration in a body fluid sample which is collected with a lancing device.
  • analytes which may be collected include glucose, lipid profiles (e.g., cholesterol, triglycerides, LDL and HDL), microalbumin, hemoglobin A1C, fructose, lactate, or bilirubin. It is contemplated that other analyte concentrations may also be determined.
  • the analytes may be in, for example, a whole blood sample, a blood serum sample, a blood plasma sample, other body fluids like ISF (interstitial fluid) and urine, and non-body fluids.
  • concentration refers to an analyte concentration, activity (e.g., enzymes and electrolytes), titers (e.g., antibodies), or any other measure concentration used to measure the desired analyte.
  • the meter 10 has a display 12 that is adapted to display information to a user of the meter 10 .
  • the meter 10 also has an interface 14 that controls the display 12 for the user.
  • the interface 14 has a plurality of predefined levels of user features that are adapted to be selected by the user.
  • the meter 10 also has at least one user input mechanism 15 that is adapted to allow the user to select one of the plurality of predefined levels of user features.
  • the user input mechanism 15 may include, for example, buttons, scroll bars, touch screens, or any combination of such items.
  • the meter 10 may also have a memory device (not shown) that is adapted to store the selected predefined level. While the remainder of the disclosure herein will be directed towards a multi-level user interface for use in glucose meters, it is to be understood that it may be implemented in meters used for determining other analytes.
  • FIGS. 1 a and 1 b show meters having some user features that may be associated with one of the plurality of predefined levels.
  • one of the plurality of predefined levels may include user features that are relatively simple and easy to understand. This level may be selected by a user who has not previously used the meter 10 or by a user who does not require more sophisticated features, i.e., a “beginner” or “novice” mode.
  • the meter 10 in FIG. 1 a includes a feature that displays a blood glucose concentration reading 20 .
  • the reading 20 includes a value associated with the blood glucose level as well as the units associated with that reading 20 .
  • 1 b also displays a feature that allows a player to store a certain number of concentration readings 22 .
  • concentration readings 22 may be stored in a memory device so that the user can retrieve the concentration readings 22 at a later time. This may be desirable so that a user can monitor his or her blood glucose readings over a period of several days.
  • This feature, and other features may be selected using the input mechanism 15 .
  • the user may use the input mechanism 15 to display a list of features that are associated with one of the plurality of predefined levels. The user is able to scroll through the list of features and select a particular feature from the list.
  • a sample and test strip icon 26 may indicate that the meter 10 is in proper working condition.
  • the reading from the test strip can then be marked using a check mark icon 27 .
  • the check mark icon 27 may be automatically applied to the test strip concentration reading by the meter 10 .
  • the meter 10 may include a buzzer or alarm that can be set by a user as a reminder to take a concentration reading 22 .
  • a buzzer icon 28 indicates that the buzzer or alarm has been set.
  • one of the plurality of predefined levels is adapted to display user features that are somewhat more sophisticated than the “beginner” level and includes features that are designed for more technically-knowledgeable users.
  • one such predefined level which may be referred to as an “intermediate” level, may include features that offer more user options for storing and displaying concentration readings.
  • user features associated with an “intermediate” level may include, in addition to the blood glucose reading 20 , a date and time indicator 30 .
  • an “intermediate” level may also include a feature that allows a user to store a greater number of concentration readings 32 .
  • at least 200 concentration readings 32 may be stored.
  • 240 readings may be stored.
  • Other user features may allow a user to calculate a multi-day average 34 of concentration readings 32 .
  • a 14-day average may be calculated as indicated in FIG. 2 c .
  • an averaging icon 26 such as an “A”, may be displayed on the meter 10 .
  • all of this information may be downloaded via a computer data interface 60 (see FIG. 4 ).
  • a meter 10 may include a feature that displays a date and time indicator 40 that can display a date and time associated with either a home time zone or a local time zone, as shown in FIG. 3 a .
  • an “advanced” level may include a feature that allows a user to store an even greater number of concentration readings 42 . In some embodiments, at least 400 concentration readings 42 may be stored. For example, as shown in the embodiment in FIG.
  • 480 readings may be stored.
  • Other user features may allow a user to calculate multiple multi-day averages 44 of concentration readings, such as 7-day, 14-day, and 30-day averages, as shown in FIG. 3 b .
  • an averaging icon 26 such as an “A”
  • Other features may allow a user to calculate morning, afternoon and evening averages (not shown). Similar to the “intermediate” level user features, all of the readings and averages may be downloaded via the computer data interface 60 (see FIG. 4 ).
  • testing alarms 52 for indicating when it is necessary for a user to take a blood glucose reading.
  • the testing alarm 52 times may be preprogrammed via the user interface or may be inputted by a user.
  • some embodiments of the present disclosure may include various markers which may be activated to associate certain events with certain concentration readings. These markers allow a user to compare the marked concentration reading with other readings taken under the same or similar conditions. Some examples of markers are shown in FIG. 3 d .
  • a pre-meal marker 46 and a post-meal marker 48 can be used to label those concentration readings that are taken before and after a meal., respectively.
  • Some other examples include a logbook marker 50 that allows a user to mark a concentration reading 22 and associate the concentration reading 22 with notes and/or comments related to that particular concentration reading 22 . These notes may relate to some condition or event that occurred before the concentration reading 22 was taken that may be helpful to a doctor who is monitoring a user's glucose levels.
  • Some other markers may include exercise markers, medication markers, fasting-time markers, and illness markers. It is contemplated that many other markers may be used with the present disclosure. All of these markers may be used to label concentration readings so that a user or doctor can associate concentration readings with certain activities that may occur during a day and that may influence the concentration readings.
  • Such “advanced” features may allow users to calculate readings associated with other analytes, such as hematocrit readings.
  • Other features may include notifying a user when high or low readings are taken. With this feature, the meter 10 may display a set of high readings and a set of low readings such that the user is able to view the range of readings and can adjust his or her diet, activities, etc. accordingly. Moreover, the high and low readings can be saved in the memory device for later retrieval by the user's doctor for further evaluation. It is contemplated that other user features may be available in an “advanced” mode, such as one or more of the features described herein with respect to the “beginner” and “intermediate” modes.
  • the glucose meter may be initially configured at a “beginner” level so that even the most technically challenged user will have a simple, straightforward glucose meter that is ready to use.
  • the more advanced levels may be selected using a setup mode that can be activated using the user input mechanism 15 . Once activated, a user can use the user input mechanism 15 to set the time, date and other user-configurable settings.
  • the glucose meter may be initially configured at an “intermediate” or “advanced” level. In yet other embodiments, the user may initially scroll through the predefined levels and select the one that most closely meets his or her needs.
  • Some commercially available meters such as those that are manufactured and/or sold by Bayer Healthcare LLC of Tarrytown, N.Y., may be redesigned to incorporate the present disclosure, such as the Ascensia® CONTOUR® Blood Glucose Monitoring System and the Ascensia® BREEZE® Blood Glucose Monitoring System. It is contemplated that other meters, in addition to the ones listed above, may incorporate the present disclosure as described herein.
  • the present disclosure thus allows a user to select certain predefined levels of user features according to his or her preferences, needs and abilities. Less sophisticated users may choose a level having fewer, simpler features, i.e., the “beginner” or “intermediate” levels, while more sophisticated users may choose a level offering additional features having more complex functions and capabilities.
  • a meter having the predefined levels as described herein can appeal to multiple user types and a single user can select other levels as his or her needs and/or understanding of the features increases.
  • a display adapted to display information to a user of the meter
  • an interface that controls the display for the user, the interface having a plurality of predefined levels of user features that are adapted to be selected by the user;
  • At least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
  • the meter according to Alternative Embodiment A further comprising a memory device adapted to store the selected predefined level.
  • a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
  • a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
  • a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
  • a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
  • a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
  • a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
  • a display adapted to display information to a user of the meter
  • an interface that controls the display for the user, the interface having at least three predefined levels of user features that are adapted to be selected by the user;
  • At least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.

Abstract

A meter adapted to determine and store an analyte concentration reading, in particular a glucose concentration reading, and including an interface having a plurality of predefined levels of user features. The predefined levels may be selected by a user based on the user's preferences, needs and abilities.

Description

    CROSS-REFERENCE AND CLAIM OF PRIORITY TO RELATED APPLICATIONS
  • This application is a divisional of U.S. patent application Ser. No. 11/989,881, filed on Feb. 1, 2008, which is a national phase filing of International Application No. PCT/US2006/030401, filed on Aug. 3, 2006, both of which claim priority to U.S. Provisional Application No. 60/705,958, filed on Aug. 5, 2005. All of the foregoing applications are incorporated herein by reference in their respective entireties.
  • FIELD OF THE INVENTION
  • The present disclosure relates generally to meters and methods of using the same, and more particularly, to a meter having a multi-level user interface that allows a user to select one of a plurality of predefined levels of user features.
  • BACKGROUND
  • The quantitative determination of analytes in body fluids is of great importance in the diagnoses and maintenance of certain physiological abnormalities. For example, lactate, cholesterol, bilirubin and glucose should be monitored in certain individuals. In particular, determining glucose in body fluids is important to diabetic individuals who must frequently check the glucose concentration in their body fluids to regulate the glucose intake in their diets.
  • Diabetic individuals often test their blood glucose levels via a blood glucose meter. Some existing glucose meters are adapted to allow users to program certain features of the glucose meter. With these types of glucose meters, the user must have some knowledge of how to program the meter or must be able to read and understand often complex user instructions. Alternatively, some glucose meters are not adapted to receive user input and instead have pre-programmed features that do not allow a user to customize the glucose meter. It would be desirable to allow a user to easily customize the glucose meter.
  • SUMMARY
  • A meter adapted to determine and store an analyte concentration reading is disclosed according to one embodiment of the present disclosure. The glucose meter includes a display adapted to display information to a user of the meter and an interface that controls the display for the user. The interface has a plurality of predefined levels of user features that are adapted to be selected by the user. The glucose meter further includes at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
  • A method for using a meter is disclosed according to one embodiment of the present disclosure. The meter is adapted to determine and store an analyte concentration reading. The meter includes a display adapted to display information to a user. The method comprises the steps of displaying information on the display via a user interface having a plurality of predefined levels of user features. The method further comprises selecting one of the plurality of predefined levels and displaying the user features associated with the selected predefined level.
  • A meter adapted to determine and store an analyte concentration reading includes a display adapted to display information to a user of the meter and an interface that controls the display for the user. The interface has at least three predefined levels of user features that are adapted to be selected by the user. The meter further includes at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
  • A method for using a meter adapted to determine and store an analyte concentration reading, in which the meter has a display adapted to display information to a user, includes the acts of displaying information on the display via a user interface having at least three predefined levels of user features, selecting one of the at least three predefined levels, and displaying the user features associated with the selected predefined level.
  • The above summary of the present disclosure is not intended to represent each embodiment, or every aspect, of the present invention. Additional features and benefits of the present disclosure are apparent from the detailed description, and figures set forth below.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1 a and 1 b are front views of a meter having a first predefined level of user features, according to one embodiment of the present disclosure.
  • FIGS. 2 a, 2 b and 2 c are front views of a meter having a second predefined level of user features, according to another embodiment of the present disclosure.
  • FIGS. 3 a, 3 b, 3 c and 3 d are front views of a meter having a third predefined level of user features, according to a further embodiment of the present disclosure.
  • FIG. 4 is a front view of a meter having a computer data interface.
  • DESCRIPTION OF ILLUSTRATED EMBODIMENTS
  • The present disclosure is directed to a meter that is adapted to determine and store an analyte concentration in a body fluid sample which is collected with a lancing device. Examples of the types of analytes which may be collected include glucose, lipid profiles (e.g., cholesterol, triglycerides, LDL and HDL), microalbumin, hemoglobin A1C, fructose, lactate, or bilirubin. It is contemplated that other analyte concentrations may also be determined. The analytes may be in, for example, a whole blood sample, a blood serum sample, a blood plasma sample, other body fluids like ISF (interstitial fluid) and urine, and non-body fluids. As used within this application, the term “concentration” refers to an analyte concentration, activity (e.g., enzymes and electrolytes), titers (e.g., antibodies), or any other measure concentration used to measure the desired analyte.
  • One embodiment of the present disclosure is a meter 10 as shown in FIGS. 1 a and 1 b. The meter 10 has a display 12 that is adapted to display information to a user of the meter 10. The meter 10 also has an interface 14 that controls the display 12 for the user. In some embodiments, the interface 14 has a plurality of predefined levels of user features that are adapted to be selected by the user. The meter 10 also has at least one user input mechanism 15 that is adapted to allow the user to select one of the plurality of predefined levels of user features. The user input mechanism 15 may include, for example, buttons, scroll bars, touch screens, or any combination of such items. The meter 10 may also have a memory device (not shown) that is adapted to store the selected predefined level. While the remainder of the disclosure herein will be directed towards a multi-level user interface for use in glucose meters, it is to be understood that it may be implemented in meters used for determining other analytes.
  • FIGS. 1 a and 1 b show meters having some user features that may be associated with one of the plurality of predefined levels. In one embodiment, one of the plurality of predefined levels may include user features that are relatively simple and easy to understand. This level may be selected by a user who has not previously used the meter 10 or by a user who does not require more sophisticated features, i.e., a “beginner” or “novice” mode. For example, the meter 10 in FIG. 1 a includes a feature that displays a blood glucose concentration reading 20. The reading 20 includes a value associated with the blood glucose level as well as the units associated with that reading 20. In addition to the concentration reading 20, the meter 10 in FIG. 1 b also displays a feature that allows a player to store a certain number of concentration readings 22. For example, in FIG. 1 b at least twenty concentration readings 22 can be stored while a user is in this “beginner” mode. The concentration readings 22 may be stored in a memory device so that the user can retrieve the concentration readings 22 at a later time. This may be desirable so that a user can monitor his or her blood glucose readings over a period of several days. This feature, and other features, may be selected using the input mechanism 15. For example, the user may use the input mechanism 15 to display a list of features that are associated with one of the plurality of predefined levels. The user is able to scroll through the list of features and select a particular feature from the list.
  • It is contemplated that other user features may be available in a “beginner” mode in addition to the features listed herein. In certain embodiments, some of these features may be “standard” features that are also available in other modes, i.e., intermediate and advanced modes. For example, one such feature, shown in FIGS. 1 a and 1 b, notifies a user of a low battery and is identified on the display 12 with a low battery icon 24. Another feature may notify the user that the temperature of the meter 10 is out of the required range for operating the meter 10. This feature may be indicated by a thermometer icon 25.
  • Other features that may be available in the “beginner” mode, as well as in other modes, may notify the user to apply a sample to a test strip. This feature may be indicated by a sample and test strip icon 26. Additionally, a user may need to use a test strip to determine that the meter 10 is in proper working condition. The reading from the test strip can then be marked using a check mark icon 27. Alternatively or additionally, the check mark icon 27 may be automatically applied to the test strip concentration reading by the meter 10. In yet other embodiments, the meter 10 may include a buzzer or alarm that can be set by a user as a reminder to take a concentration reading 22. A buzzer icon 28 indicates that the buzzer or alarm has been set.
  • In addition to storing a certain number of concentration readings, additional user features may be available. For instance, in another embodiment of the present disclosure, one of the plurality of predefined levels is adapted to display user features that are somewhat more sophisticated than the “beginner” level and includes features that are designed for more technically-knowledgeable users. As shown in FIGS. 2 a, 2 b and 2 c, one such predefined level, which may be referred to as an “intermediate” level, may include features that offer more user options for storing and displaying concentration readings. For example, user features associated with an “intermediate” level may include, in addition to the blood glucose reading 20, a date and time indicator 30. Additionally, an “intermediate” level may also include a feature that allows a user to store a greater number of concentration readings 32. In some embodiments, at least 200 concentration readings 32 may be stored. For example, as shown in the embodiment in FIG. 2 b, 240 readings may be stored. Other user features may allow a user to calculate a multi-day average 34 of concentration readings 32. For example, a 14-day average may be calculated as indicated in FIG. 2 c. To indicate that the averaging feature is in use, an averaging icon 26, such as an “A”, may be displayed on the meter 10. Furthermore, all of this information may be downloaded via a computer data interface 60 (see FIG. 4). These user features provide more ways of storing, displaying and calculating information that may be important to a user of the meter 10. In addition, doctors or other medical professionals may desire to have this information available to them as a way of monitoring the blood glucose levels of their patients.
  • It is contemplated that other user features may be available in an “intermediate” mode in addition to the features listed herein, such as one or more of the features described herein with respect to the “beginner” mode.
  • In addition to the “beginner” and “intermediate” levels described above, additional user features may be included in a third predefined level. This level, as depicted in FIGS. 3 a, 3 b, 3 c and 3 d, may be associated with user features that are more advanced than other levels. For example, a meter 10 may include a feature that displays a date and time indicator 40 that can display a date and time associated with either a home time zone or a local time zone, as shown in FIG. 3 a. Additionally, an “advanced” level may include a feature that allows a user to store an even greater number of concentration readings 42. In some embodiments, at least 400 concentration readings 42 may be stored. For example, as shown in the embodiment in FIG. 3 c, 480 readings may be stored. Other user features may allow a user to calculate multiple multi-day averages 44 of concentration readings, such as 7-day, 14-day, and 30-day averages, as shown in FIG. 3 b. As in the “intermediate” mode, to indicate that the averaging feature is in use, an averaging icon 26, such as an “A”, may be displayed on the meter 10. Other features may allow a user to calculate morning, afternoon and evening averages (not shown). Similar to the “intermediate” level user features, all of the readings and averages may be downloaded via the computer data interface 60 (see FIG. 4).
  • Other user features that may be included in an “advanced” level may include testing alarms 52 for indicating when it is necessary for a user to take a blood glucose reading. The testing alarm 52 times may be preprogrammed via the user interface or may be inputted by a user. In addition to a testing alarm 52, some embodiments of the present disclosure may include various markers which may be activated to associate certain events with certain concentration readings. These markers allow a user to compare the marked concentration reading with other readings taken under the same or similar conditions. Some examples of markers are shown in FIG. 3 d. A pre-meal marker 46 and a post-meal marker 48 can be used to label those concentration readings that are taken before and after a meal., respectively. Some other examples include a logbook marker 50 that allows a user to mark a concentration reading 22 and associate the concentration reading 22 with notes and/or comments related to that particular concentration reading 22. These notes may relate to some condition or event that occurred before the concentration reading 22 was taken that may be helpful to a doctor who is monitoring a user's glucose levels. Some other markers may include exercise markers, medication markers, fasting-time markers, and illness markers. It is contemplated that many other markers may be used with the present disclosure. All of these markers may be used to label concentration readings so that a user or doctor can associate concentration readings with certain activities that may occur during a day and that may influence the concentration readings.
  • It is contemplated that other user features may be available in an “advanced” mode in addition to the features listed herein. Such “advanced” features may allow users to calculate readings associated with other analytes, such as hematocrit readings. Other features may include notifying a user when high or low readings are taken. With this feature, the meter 10 may display a set of high readings and a set of low readings such that the user is able to view the range of readings and can adjust his or her diet, activities, etc. accordingly. Moreover, the high and low readings can be saved in the memory device for later retrieval by the user's doctor for further evaluation. It is contemplated that other user features may be available in an “advanced” mode, such as one or more of the features described herein with respect to the “beginner” and “intermediate” modes.
  • In some embodiments, the glucose meter may be initially configured at a “beginner” level so that even the most technically challenged user will have a simple, straightforward glucose meter that is ready to use. The more advanced levels may be selected using a setup mode that can be activated using the user input mechanism 15. Once activated, a user can use the user input mechanism 15 to set the time, date and other user-configurable settings. In other embodiments, the glucose meter may be initially configured at an “intermediate” or “advanced” level. In yet other embodiments, the user may initially scroll through the predefined levels and select the one that most closely meets his or her needs.
  • Some commercially available meters, such as those that are manufactured and/or sold by Bayer Healthcare LLC of Tarrytown, N.Y., may be redesigned to incorporate the present disclosure, such as the Ascensia® CONTOUR® Blood Glucose Monitoring System and the Ascensia® BREEZE® Blood Glucose Monitoring System. It is contemplated that other meters, in addition to the ones listed above, may incorporate the present disclosure as described herein.
  • The present disclosure thus allows a user to select certain predefined levels of user features according to his or her preferences, needs and abilities. Less sophisticated users may choose a level having fewer, simpler features, i.e., the “beginner” or “intermediate” levels, while more sophisticated users may choose a level offering additional features having more complex functions and capabilities. A meter having the predefined levels as described herein can appeal to multiple user types and a single user can select other levels as his or her needs and/or understanding of the features increases.
  • ALTERNATIVE EMBODIMENT A
  • A meter adapted to determine and store an analyte concentration reading, the meter comprising:
  • a display adapted to display information to a user of the meter;
  • an interface that controls the display for the user, the interface having a plurality of predefined levels of user features that are adapted to be selected by the user; and
  • at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
  • ALTERNATIVE EMBODIMENT B
  • The meter according to Alternative Embodiment A, further comprising a memory device adapted to store the selected predefined level.
  • ALTERNATIVE EMBODIMENT C
  • The meter according to Alternative Embodiment A, wherein the analyte is glucose.
  • ALTERNATIVE EMBODIMENT D
  • The meter according to Alternative Embodiment A, wherein the plurality of predefined levels includes at least three predefined levels.
  • ALTERNATIVE EMBODIMENT E
  • The meter according to Alternative Embodiment D, wherein a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
  • ALTERNATIVE EMBODIMENT F
  • The meter according to Alternative Embodiment D, wherein a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
  • ALTERNATIVE EMBODIMENT G
  • The meter according to embodiment D, wherein a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
  • ALTERNATIVE PROCESS H
  • A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising the acts of:
  • displaying information on the display via a user interface, the interface having a plurality of predefined levels of user features;
  • selecting one of the plurality of predefined levels; and
  • displaying the user features associated with the selected predefined level.
  • ALTERNATIVE PROCESS I
  • The method according to Alternative Process H, further comprising storing the selected predefined level.
  • ALTERNATIVE PROCESS J
  • The method according to Alternative Process H, wherein the analyte is glucose.
  • ALTERNATIVE PROCESS K
  • The method according to Alternative Process H, wherein the plurality of predefined levels includes at least three predefined levels.
  • ALTERNATIVE PROCESS L
  • The method according to Alternative Process K, wherein a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
  • ALTERNATIVE PROCESS M
  • The method according to Alternative Process K, wherein a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
  • ALTERNATIVE PROCESS N
  • The method according to Alternative Process K, wherein a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
  • ALTERNATIVE EMBODIMENT O
  • A meter adapted to determine and store an analyte concentration reading, the meter comprising:
  • a display adapted to display information to a user of the meter;
  • an interface that controls the display for the user, the interface having at least three predefined levels of user features that are adapted to be selected by the user; and
  • at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
  • ALTERNATIVE PROCESS P
  • A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising the acts of:
  • displaying information on the display via a user interface, the interface having at least three predefined levels of user features;
  • selecting one of the at least three predefined levels; and
  • displaying the user features associated with the selected predefined level.
  • While the disclosure is susceptible to various modifications and alternative forms, specific embodiments and methods thereof have been shown by way of example in the drawings and are described in detail herein. It should be understood, however, that it is not intended to limit the invention to the particular forms or methods disclosed, but, to the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the invention as defined by the appended claims.

Claims (16)

1. A meter adapted to determine and store an analyte concentration reading, the meter comprising:
a display adapted to display information to a user of the meter;
an interface that controls the display for the user, the interface having a plurality of predefined levels of user features that are selectable by the user, the plurality of predefined levels including at least a first predefined level and a second predefined level, the first predefined level displaying the analyte concentration, and the second predefined level displaying the analyte concentration and including at least one second level user feature excluded from the first predefined level; and
at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
2. The meter according to claim 1, further comprising a memory device adapted to store the selected predefined level.
3. The meter according to claim 1, wherein the analyte is glucose.
4. The meter according to claim 1, wherein the first predefined level includes a user feature for saving at least twenty concentration readings.
5. The meter according to claim 1, wherein the second predefined level includes user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time, and for downloading the concentration readings via a computer data interface.
6. The meter according to claim 1, wherein the plurality of predefined levels also includes at least a third predefined level, the third predefined level displaying the analyte concentration and including at least a third user feature excluded from the first and the second predefined levels.
7. The meter according to claim 6, wherein the third predefined level includes user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
8. A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising:
displaying information on the display via a user interface, the interface having a plurality of predefined levels of user features, the plurality of predefined levels is including at least a first predefined level and a second predefined level, the first predefined level displaying the analyte concentration, and the second predefined level displaying the analyte concentration and including at least one second level user feature excluded from the first predefined level;
selecting one of the plurality of predefined levels; and
displaying the user features associated with the selected predefined level.
9. The method according to claim 8, further comprising storing the selected predefined level.
10. The method according to claim 8, wherein the analyte is glucose.
11. The method according to claim 8, wherein the first predefined level includes a user feature for saving at least twenty concentration readings.
12. The method according to claim 8, wherein the second predefined level includes user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
13. The method according to claim 8, wherein the plurality of predefined levels also includes at least a third predefined level, the third predefined level displaying the analyte concentration and including at least a third user feature excluded from the first and the second predefined level.
14. The method according to claim 11, wherein the third predefined level includes user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
15. A meter adapted to determine and store an analyte concentration reading, the meter comprising:
a display adapted to display information to a user of the meter;
an interface that controls the display for the user, the interface having at least three predefined levels of user features that are adapted to be selected by the user, the at least three predefined levels including a beginner level, an intermediate level, and an advanced level, the beginner level including a first user feature adapted to store a set of information of a first size, the intermediate level including a second user feature adapted to store a set of information of a second size greater than the first size, and the advanced level including a third user feature adapted to store a set of information of a third size greater than the second size; and
at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
16. A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising the acts of:
displaying information on the display via a user interface, the interface having at least three predefined levels of user features, the at least three predefined levels including a beginner level, an intermediate level, and an advanced level, the beginner level including a first user feature adapted to store a set of information of a first size, the intermediate level including a second user feature adapted to store a set of information of a second size greater than the first size, and the advanced level including a third user feature adapted to store a set of information of a third size greater than the second size;
selecting one of the at least three predefined levels; and
displaying the user features associated with the selected predefined level.
US13/028,308 2005-08-05 2011-02-16 Meter having multi-level user interface Abandoned US20110137571A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/028,308 US20110137571A1 (en) 2005-08-05 2011-02-16 Meter having multi-level user interface

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70595805P 2005-08-05 2005-08-05
PCT/US2006/030401 WO2007019289A1 (en) 2005-08-05 2006-08-03 Meter having multi-level user interface
US98988108A 2008-02-01 2008-02-01
US13/028,308 US20110137571A1 (en) 2005-08-05 2011-02-16 Meter having multi-level user interface

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2006/030401 Division WO2007019289A1 (en) 2005-08-05 2006-08-03 Meter having multi-level user interface
US98988108A Division 2005-08-05 2008-02-01

Publications (1)

Publication Number Publication Date
US20110137571A1 true US20110137571A1 (en) 2011-06-09

Family

ID=37116111

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/989,881 Active 2027-08-29 US7912655B2 (en) 2005-08-05 2006-08-03 Meter having multi-level user interface
US13/028,308 Abandoned US20110137571A1 (en) 2005-08-05 2011-02-16 Meter having multi-level user interface

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/989,881 Active 2027-08-29 US7912655B2 (en) 2005-08-05 2006-08-03 Meter having multi-level user interface

Country Status (18)

Country Link
US (2) US7912655B2 (en)
EP (1) EP1913383B1 (en)
JP (1) JP5528701B2 (en)
KR (1) KR20080034979A (en)
CN (2) CN103776991B (en)
AR (1) AR054899A1 (en)
AU (1) AU2006278537A1 (en)
BR (1) BRPI0614118A2 (en)
CA (1) CA2617965C (en)
DO (1) DOP2006000181A (en)
HK (1) HK1197451A1 (en)
MX (1) MX2008001713A (en)
NO (1) NO20081165L (en)
RU (1) RU2411001C2 (en)
TW (1) TWI417543B (en)
UY (1) UY29720A1 (en)
WO (1) WO2007019289A1 (en)
ZA (1) ZA200801265B (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1913383A1 (en) 2005-08-05 2008-04-23 Bayer HealthCare LLC Meter having multi-level user interface
US20100280782A1 (en) * 2009-04-29 2010-11-04 Abbott Diabetes Care Inc. Method and System for Providing Real Time Analyte Sensor Calibration with Retrospective Backfill
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8514086B2 (en) 2009-08-31 2013-08-20 Abbott Diabetes Care Inc. Displays for a medical device
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US8974746B2 (en) 2010-09-16 2015-03-10 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device for medical institutions
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9529503B2 (en) 2013-06-27 2016-12-27 Lifescan Scotland Limited Analyte-measurement system recording user menu choices
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9921208B2 (en) 2012-07-26 2018-03-20 Ascensia Diabetes Care Holdings Ag Apparatus and methods for reducing electrical shock hazard from biosensor meters
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US20210398663A1 (en) * 2006-10-31 2021-12-23 Abbott Diabetes Care Inc. Infusion Devices and Methods
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11896371B2 (en) 2012-09-26 2024-02-13 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8920343B2 (en) 2006-03-23 2014-12-30 Michael Edward Sabatino Apparatus for acquiring and processing of physiological auditory signals
US9052797B2 (en) * 2007-09-26 2015-06-09 Autodesk, Inc. Navigation system for a 3D virtual scene
IL197532A0 (en) 2008-03-21 2009-12-24 Lifescan Scotland Ltd Analyte testing method and system
EP2130487A1 (en) * 2008-06-03 2009-12-09 Microlife Intellectual Property GmbH Glucose meter, a system with a glucose meter, method for operating a glucose meter and a computer program product
SG159459A1 (en) * 2008-08-15 2010-03-30 Lifescan Scotland Ltd Analyte testing method and system
BRPI1016004A2 (en) 2009-06-30 2016-04-26 Lifescan Inc methods for testing analytes and device for calculating basal insulin therapy.
BR112012007134A2 (en) 2009-09-29 2016-08-23 Lifescan Scotland Ltd diabetes control analyte test device and method
EP2590098B1 (en) 2010-02-25 2014-11-05 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
CA2794104A1 (en) * 2010-03-31 2011-10-06 Animas Corporation Method and system to display analyte sensor data
JP2011247884A (en) * 2010-04-30 2011-12-08 Arkray Inc Monitoring apparatus, monitoring method and program
US8982056B2 (en) * 2011-03-15 2015-03-17 Rosemount Inc. Software rotatable display
DE102011016546A1 (en) * 2011-04-08 2012-10-11 Abb Ag Electronic installation device for recording and storing health, fitness, wellness and vital data
US9136939B2 (en) 2011-12-29 2015-09-15 Roche Diabetes Care, Inc. Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device
KR101320555B1 (en) 2012-05-09 2013-11-06 (주)세종바이오테크놀로지 System for measuring blood sugar level
US9119529B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US9826925B2 (en) * 2012-11-29 2017-11-28 Lifescan, Inc. Analyte meter with basic and advanced meter preset mode selection based on structured queries
USD698443S1 (en) 2013-01-07 2014-01-28 Bayer Healthcare Llc Monitoring system
US20140240359A1 (en) * 2013-02-27 2014-08-28 Lifescan Scotland Limited Portable analyte meter with enhanced measurement display
CN104473651A (en) * 2014-12-17 2015-04-01 杜清静 Infrared spectrum technology non-invasive blood glucose instrument
EP3517968B1 (en) * 2016-09-21 2022-11-09 Hitachi High-Tech Corporation Automated analysis device
USD879837S1 (en) 2017-06-13 2020-03-31 Maschinenfabrik Reinhausen Gmbh Measuring instrument face with surface ornamentation
CN107280680A (en) * 2017-06-15 2017-10-24 北京乐糖生活科技有限公司 Blood sugar real-time monitoring system and the blood Sugar Monitoring method based on the system

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4763117A (en) * 1983-03-23 1988-08-09 Tektronix, Inc. Measurement instruments with multiple operation levels
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5365935A (en) * 1991-09-10 1994-11-22 Ralin, Inc. Portable, multi-channel ECG data monitor/recorder
US5997475A (en) * 1997-08-18 1999-12-07 Solefound, Inc. Device for diabetes management
US6505059B1 (en) * 1998-04-06 2003-01-07 The General Hospital Corporation Non-invasive tissue glucose level monitoring
US20030032190A1 (en) * 2001-08-13 2003-02-13 Brown Michael K. Mechanical mechanism for a blood glucose sensor dispensing instrument
US20030093437A1 (en) * 2001-07-16 2003-05-15 Ullas Gargi Hierarchical image feature-based visualization
US20030211617A1 (en) * 2002-05-07 2003-11-13 International Business Machines Corporation Blood glucose meter that reminds the user to test after a hypoglycemic event
US20050120313A1 (en) * 2001-10-09 2005-06-02 Rudd Michael L. System and method for personalizing an electrical device interface

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3462555D1 (en) * 1983-03-23 1987-04-09 Tektronix Inc Measurement instruments with multiple operation levels
JPH02112098A (en) * 1988-10-21 1990-04-24 Hitachi Ltd Information selection presenting device
KR100627990B1 (en) 1998-11-30 2006-09-26 노보 노르디스크 에이/에스 A method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions
JP2004028605A (en) * 2002-06-21 2004-01-29 Mitsutoyo Corp Measuring instrument and steerable restriction method of measuring instrument constellation
EP1680014A4 (en) * 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
CN1605965A (en) * 2004-03-29 2005-04-13 梁振宇 Network financial user management system
TWI417543B (en) 2005-08-05 2013-12-01 Bayer Healthcare Llc Meters and method of using meters having a multi-level user interface with predefined levels of user features

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4763117A (en) * 1983-03-23 1988-08-09 Tektronix, Inc. Measurement instruments with multiple operation levels
US5365935A (en) * 1991-09-10 1994-11-22 Ralin, Inc. Portable, multi-channel ECG data monitor/recorder
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5997475A (en) * 1997-08-18 1999-12-07 Solefound, Inc. Device for diabetes management
US6505059B1 (en) * 1998-04-06 2003-01-07 The General Hospital Corporation Non-invasive tissue glucose level monitoring
US20030093437A1 (en) * 2001-07-16 2003-05-15 Ullas Gargi Hierarchical image feature-based visualization
US20030032190A1 (en) * 2001-08-13 2003-02-13 Brown Michael K. Mechanical mechanism for a blood glucose sensor dispensing instrument
US6997344B2 (en) * 2001-08-13 2006-02-14 Bayer Healthcare Llc Automated mechanical mechanism for a blood glucose sensor dispensing instrument
US20050120313A1 (en) * 2001-10-09 2005-06-02 Rudd Michael L. System and method for personalizing an electrical device interface
US20030211617A1 (en) * 2002-05-07 2003-11-13 International Business Machines Corporation Blood glucose meter that reminds the user to test after a hypoglycemic event

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1913383A1 (en) 2005-08-05 2008-04-23 Bayer HealthCare LLC Meter having multi-level user interface
US20220013224A1 (en) * 2006-10-31 2022-01-13 Abbott Diabetes Care Inc. Infusion Devices and Methods
US11837358B2 (en) * 2006-10-31 2023-12-05 Abbott Diabetes Care Inc. Infusion devices and methods
US20230064839A1 (en) * 2006-10-31 2023-03-02 Abbott Diabetes Care Inc. Infusion device and methods
US11508476B2 (en) * 2006-10-31 2022-11-22 Abbott Diabetes Care, Inc. Infusion devices and methods
US20210398663A1 (en) * 2006-10-31 2021-12-23 Abbott Diabetes Care Inc. Infusion Devices and Methods
US11264133B2 (en) 2007-06-21 2022-03-01 Abbott Diabetes Care Inc. Health management devices and methods
US11276492B2 (en) 2007-06-21 2022-03-15 Abbott Diabetes Care Inc. Health management devices and methods
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US11779248B2 (en) 2008-03-28 2023-10-10 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9730623B2 (en) 2008-03-28 2017-08-15 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9320462B2 (en) 2008-03-28 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8718739B2 (en) 2008-03-28 2014-05-06 Abbott Diabetes Care Inc. Analyte sensor calibration management
US10463288B2 (en) 2008-03-28 2019-11-05 Abbott Diabetes Care Inc. Analyte sensor calibration management
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US8730058B2 (en) 2009-04-15 2014-05-20 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US9178752B2 (en) 2009-04-15 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US10009244B2 (en) 2009-04-15 2018-06-26 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US20100280782A1 (en) * 2009-04-29 2010-11-04 Abbott Diabetes Care Inc. Method and System for Providing Real Time Analyte Sensor Calibration with Retrospective Backfill
US9310230B2 (en) 2009-04-29 2016-04-12 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US9186113B2 (en) 2009-08-31 2015-11-17 Abbott Diabetes Care Inc. Displays for a medical device
US11730429B2 (en) 2009-08-31 2023-08-22 Abbott Diabetes Care Inc. Displays for a medical device
USRE47315E1 (en) 2009-08-31 2019-03-26 Abbott Diabetes Care Inc. Displays for a medical device
US10492685B2 (en) 2009-08-31 2019-12-03 Abbott Diabetes Care Inc. Medical devices and methods
US10772572B2 (en) 2009-08-31 2020-09-15 Abbott Diabetes Care Inc. Displays for a medical device
US10881355B2 (en) 2009-08-31 2021-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US10918342B1 (en) 2009-08-31 2021-02-16 Abbott Diabetes Care Inc. Displays for a medical device
US8514086B2 (en) 2009-08-31 2013-08-20 Abbott Diabetes Care Inc. Displays for a medical device
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US10123752B2 (en) 2009-08-31 2018-11-13 Abbott Diabetes Care Inc. Displays for a medical device
USD1010133S1 (en) 2009-08-31 2024-01-02 Abbott Diabetes Care Inc. Analyte sensor assembly
US11202586B2 (en) 2009-08-31 2021-12-21 Abbott Diabetes Care Inc. Displays for a medical device
US8816862B2 (en) 2009-08-31 2014-08-26 Abbott Diabetes Care Inc. Displays for a medical device
US9814416B2 (en) 2009-08-31 2017-11-14 Abbott Diabetes Care Inc. Displays for a medical device
US9549694B2 (en) 2009-08-31 2017-01-24 Abbott Diabetes Care Inc. Displays for a medical device
US10456091B2 (en) 2009-08-31 2019-10-29 Abbott Diabetes Care Inc. Displays for a medical device
US11241175B2 (en) 2009-08-31 2022-02-08 Abbott Diabetes Care Inc. Displays for a medical device
US9226714B2 (en) 2009-08-31 2016-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US8974746B2 (en) 2010-09-16 2015-03-10 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device for medical institutions
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9465420B2 (en) 2011-10-31 2016-10-11 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US11391723B2 (en) 2011-11-25 2022-07-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US10082493B2 (en) 2011-11-25 2018-09-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9921208B2 (en) 2012-07-26 2018-03-20 Ascensia Diabetes Care Holdings Ag Apparatus and methods for reducing electrical shock hazard from biosensor meters
US11896371B2 (en) 2012-09-26 2024-02-13 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US9529503B2 (en) 2013-06-27 2016-12-27 Lifescan Scotland Limited Analyte-measurement system recording user menu choices
US10210538B2 (en) 2013-06-27 2019-02-19 Lifescan Ip Holdings, Llc Analyte-measurement system recording user menu choices

Also Published As

Publication number Publication date
JP5528701B2 (en) 2014-06-25
BRPI0614118A2 (en) 2011-03-09
CN103776991A (en) 2014-05-07
DOP2006000181A (en) 2007-03-15
HK1197451A1 (en) 2015-01-16
TW200722753A (en) 2007-06-16
JP2009502438A (en) 2009-01-29
CA2617965A1 (en) 2007-02-15
MX2008001713A (en) 2008-04-07
UY29720A1 (en) 2007-03-30
RU2411001C2 (en) 2011-02-10
ZA200801265B (en) 2009-08-26
TWI417543B (en) 2013-12-01
CA2617965C (en) 2011-10-18
US7912655B2 (en) 2011-03-22
RU2008108506A (en) 2009-09-10
US20090093972A1 (en) 2009-04-09
CN101238368A (en) 2008-08-06
KR20080034979A (en) 2008-04-22
NO20081165L (en) 2008-05-05
AU2006278537A1 (en) 2007-02-15
AR054899A1 (en) 2007-07-25
EP1913383B1 (en) 2018-08-01
WO2007019289A1 (en) 2007-02-15
CN103776991B (en) 2016-03-16
EP1913383A1 (en) 2008-04-23

Similar Documents

Publication Publication Date Title
US7912655B2 (en) Meter having multi-level user interface
US10546482B2 (en) Device having post-meal test-time alarm
JP6553152B2 (en) Interface for Health Measurement and Monitoring System
US20080208509A1 (en) System and method for graphically plotting and displaying analyte concentration data on a calendar
EP2134251B1 (en) Method for using a meter adapted to simultaneously display the number of high, low and total test results
WO2007030457A1 (en) Test meter having time and date correction and method for correcting the same

Legal Events

Date Code Title Description
AS Assignment

Owner name: BARNES HEALTHCARE LLC, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POWER, BARRY D.;CULVER, JEFFREY A.;SIGNING DATES FROM 20050808 TO 20050920;REEL/FRAME:025815/0641

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: ASCENSIA DIABETES CARE HOLDINGS AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER HEALTHCARE LLC;REEL/FRAME:037880/0604

Effective date: 20160104